Skip to contentD
DexCom Inc
D
DXCMDexCom Inc Q4 2024 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$1.11B$1.11Bderived+7.6% vs Q4 2023 Net Income$151.70M$151.70Mderived−40.8% vs Q4 2023 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
DexCom Inc · CIK 1093557 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Gross Profitderived$655,800,000−0.1% Operating Incomederived$188,900,000−12.9% Operating Cash Flowderived$301,400,000+125.6% Free Cash Flowderived$176,800,000+118.0% Margins · derivedGross margin58.9%−4.6 pt vs Q4 2023
Operating margin17.0%−4.0 pt vs Q4 2023
Net margin13.6%−11.2 pt vs Q4 2023
ended Dec 31, 2024 · filed Feb 18, 2025 · 49 d after period end